Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Patent Set for Peptide Nerve Damage Treatments

The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4. . . . → Read More: Patent Set for Peptide Nerve Damage Treatments

Creative Ideas Mined with Crowdsourcing, Neural Nets

A computer science team developed a process that combines crowdsourcing and artificial intelligence to find analogies across disciplines to spark creative ideas. . . . → Read More: Creative Ideas Mined with Crowdsourcing, Neural Nets

Patent Awarded for Exosome Capture Process

A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses. . . . → Read More: Patent Awarded for Exosome Capture Process

Broad Institute in Crispr Licensing Program

One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology. . . . → Read More: Broad Institute in Crispr Licensing Program

Patent Awarded for COPD Dry Powder Inhaler Formula

A formulation for dry powder inhalers to treat respiratory diseases that its developers say delivers medication to the lungs more efficiently received a U.S. patent. . . . → Read More: Patent Awarded for COPD Dry Powder Inhaler Formula

NIH Funds Seen Boosting Industry Patents

An analysis of grants issued by National Institutes of Health shows a large percentage of those grants, directly or indirectly, result in patented technologies in industry. . . . → Read More: NIH Funds Seen Boosting Industry Patents

Univ. of California to Gain European Crispr-Cas9 Patent

A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques. . . . → Read More: Univ. of California to Gain European Crispr-Cas9 Patent

Patent Issued for Peptides in Diabetes Gene Therapy

A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure. . . . → Read More: Patent Issued for Peptides in Diabetes Gene Therapy

Patent Office Decides for Broad and Editas in Crispr Case

The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley. . . . → Read More: Patent Office Decides for Broad and Editas in Crispr Case

Simpler Lab Cell Production Techniques Devised

A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research. . . . → Read More: Simpler Lab Cell Production Techniques Devised